We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

59 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $5.92M | Put options by funds: $2.91M

0% more funds holding

Funds holding: 59 → 59 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

1.79% less ownership

Funds ownership: 26.38% → 24.59% (-1.8%)

19% less capital invested

Capital invested by funds: $151M → $123M (-$28.1M)

26% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 23

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
59
Holders Change
–
Holders Change %
0%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
17
Reduced
23
Closed
8
Calls
$5.92M
Puts
$2.91M
Net Calls
+$3.01M
Net Calls Change
+$3.1M

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$3.75M
2
LTFS
Ladenburg Thalmann Financial Services
Florida
+$973K
3
GP
GLG Partners
United Kingdom
+$830K
4
NES
New England Securities
New York
+$632K
5
DAS
Dynamic Advisor Solutions
Arizona
+$603K

Top Sellers

Rank Fund Capital Flow
1
NCM
Niemann Capital Management
Nevada
-$14.4M
2
CS
Credit Suisse
Switzerland
-$4.78M
3
Citigroup
Citigroup
New York
-$4.49M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.71M
5
TRCT
Tower Research Capital (TRC)
New York
-$2.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
FANJ
51
Financial Architects (New Jersey)
New Jersey
$57K +$53.8K +600 New
WEC
52
Winslow Evans & Crocker
Massachusetts
$45.3K +$8.96K +100 +27%
KPCM
53
Kings Point Capital Management
New York
$26K – – –
AF
54
Arrow Financial
New York
$24K – – –
BFEC
55
Benjamin F. Edwards & Company
Missouri
$24K +$22.4K +250 New
PIM
56
Parasol Investment Management
Illinois
$14K – – –
US Bancorp
57
US Bancorp
Minnesota
$14K – – –
WA
58
WFG Advisors
Texas
$6K – – –
Northwestern Mutual Wealth Management
59
Northwestern Mutual Wealth Management
Wisconsin
$6K +$5.74K +64 New
NCM
60
Niemann Capital Management
Nevada
– -$14.4M -157,929 Closed
Envestnet Asset Management
61
Envestnet Asset Management
Illinois
– -$873K -9,598 Closed
BPCE
62
Bank Pictet & Cie (Europe)
Germany
– -$676K -7,430 Closed
Jane Street
63
Jane Street
New York
– -$495K -5,517 Closed
UCFA
64
United Capital Financial Advisors
Texas
– -$436K -4,790 Closed
RG
65
Redmile Group
California
– -$292K -3,208 Closed
FAAS
66
First Allied Advisory Services
California
– -$226K -2,533 Closed
Bessemer Group
67
Bessemer Group
New Jersey
– -$7K -74 Closed
1 2
3

BBH Hedge Fund Activity: Q2 2014 in Review

59 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2014, worth a combined $123M — down 19% from $151M a quarter earlier.

Fund positioning in BBH was balanced in Q2 2014: 8 funds opened new positions, 8 closed out, 17 added to existing stakes and 23 trimmed.

The largest buyer was UBS, adding an estimated $3.75M. The largest seller was Niemann Capital Management, exiting entirely with an estimated $14.4M sold.

  • 59 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $123M of VanEck Biotech ETF stock for Q2 2014, down 19% quarter-over-quarter.
  • 8 funds opened new VanEck Biotech ETF positions in Q2 2014 and 8 closed out, a net change of 0 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2014 was UBS, an estimated $3.75M added.
  • The largest VanEck Biotech ETF seller in Q2 2014 was Niemann Capital Management, an estimated $14.4M sold.

Based on aggregated 13F filings for Q2 2014.